News

Dan Myers Named Director of Virginia SBDC, Innovation Commercialization Assistance Program to Accelerate Tech-Driven Growth in the Commonwealth

The Virginia Small Business Development Center (SBDC) is pleased to announce that Dan Myers has been named the new Director for the Virginia SBDC – Innovation Commercialization Assistance Program (ICAP).

Dan, a seasoned innovation strategist, will lead the Virginia SBDC – ICAP program that is designed to help Virginia small businesses turn ideas into commercial success. In his new role, Dan will lead the program efforts to support Virginia based innovators and entrepreneurs in bringing high potential technologies and innovations to market, strengthening the state’s innovation ecosystem and advancing economic growth.

With years of experience in innovation management, technology transfer, and startup acceleration, Dan brings a proven track record of guiding early-stage technologies from concept to commercialization. Prior to this new role, he served as a Virginia SBDC – ICAP mentor. Dan will now oversee the program team, develop strategic partnerships, and expand outreach to innovation communities across Virginia.

“Virginia is at a critical inflection point in building a vibrant innovation economy,” said Jody Keenan, State Director of the Virginia SBDC Network. “With Dan on board, we’re committed to move ideas off the bench and into real businesses that create jobs and add value here in the Commonwealth.”

“We live in a moment where Virginia’s entrepreneurial talent, research institutions, and industry partners are aligning,” said Dan Myers. “My priority is to remove friction from the path of innovation so that bright ideas become meaningfully impactful businesses and challenges in the world find built solutions. That means working hand in hand with entrepreneurs, universities, and ecosystem partners in order to see early-stage tech startups, biotech & bioscience companies, and other scalable businesses thrive in Virginia.”

Recent News

09/17/2026

Rivanna Announces New CMS Procedure Code for Computer-aided Neuraxial Guidance

RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the Centers for Medicare & Medicaid Services (CMS) has established ICD-10-PCS code XEZU3HC, effective for inpatient discharges beginning October 1, 2026. The code identifies computer-aided intraprocedural navigation in the spinal canal using ultrasound imaging with continuous needle tracking via a percutaneous approach during neuraxial anesthesia.

09/17/2026

From Lab to Three Continents: Agrospheres and FMC Corporation Advance Bioinsecticide Pipeline into Global Field Trials

AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection and FMC Corporation (NYSE: FMC), a global leader in agricultural sciences, today announced a significant advancement in its ongoing collaboration. Two proprietary RNA-based biomolecule candidates from AgroSpheres’ pipeline are now entering global field trial development, marking the transition from discovery into real-world testing across three

09/15/2026

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (“Jazz” or the “Company”) today announced the successful completion of its acquisition of privately-held Actio Biosciences, Inc. (“Actio”) for $820 million upfront. Actio is now a wholly-owned subsidiary of Jazz. “ABS-1230 holds the promise of being a transformative, first-in-class therapy for individuals living with KCNT1-related epilepsy,” said Renee Gala, president and